PDL BioPharma Inc (PDLI)
Delisted
6 Jan 2021
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 47
0
0%
$
282.14M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 2.47
Previous Close Investors:
Day Range
2.47 2.47
Year Range
2.09 3.86
Want to track PDLI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.
PDLI Chart
PDL BioPharma Inc Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| AH Andrew Heistad Mason Street Advisors LLC | 30,100 | $516,000 | $516,000 | - | - |
PDL BioPharma Inc (PDLI) FAQ
What does "Delisted" mean?
PDL BioPharma Inc has been removed from the exchange and is no longer publicly traded.
What was the last recorded dividend?
The last recorded dividend was paid on Sep 21, 2020 in the amount of $0.08 per share.
How long did the company pay dividends?
The company paid dividends for 12 years prior to delisting.
Were there any stock splits?
The last recorded stock split occurred on Oct 10, 2001 with a ratio of 2:1.
What was the last known trading price?
The stock last traded at $2.47 on Jan 06, 2021 before being delisted.
